We advised Knudsen Plast, a leading CDMO (Contract Development and Manufacturing Organisation) specialising in injection‑moulded plastic solutions for the healthcare industry, on its sale to MGS, a global healthcare CDMO.
Headquartered in Frederiksværk, Denmark, Knudsen Plast brings over 40 years of expertise in product and production maturation, precision injection moulding and quality control. The company operates ISO 13485-certified facilities in Denmark and Slovakia and employs more than 200 people, supporting leading European medical and healthcare clients from development through to high‑quality series production.
MGS, headquartered in Wisconsin, US, is a global CDMO serving the healthcare and pharmaceutical markets. With 13 sites worldwide, MGS is recognised for its precision plastics capabilities and vertically integrated, end‑to‑end solutions across the entire value chain.
The combination of the two companies creates an even stronger one‑stop shop for customers in the Medico and Pharma segments, with an enhanced presence across North America and Europe, while enabling further investment in Knudsen Plast’s future growth.